The global bacillus coagulans market is anticipated to reach market size of around US$ 130 Mn by 2027 and is anticipated to grow at a CAGR of around 8% in terms of revenue during the forecast period 2020 – 2027.
Bacillus coagulans is like other probiosis types of good bacteria. Bacillus coagulans help to support gastrointestinal disorders and digestive problems in general. It also prevents respiratory diseases and stimulates the immune system. But, in contrast to lactic acid bacteria, bacillus coagulans form a reproductive structure, called spores. Bacillus coagulans produce lactic acid. These springs are essential to and distinguish between bacillus coagulans and other lactic acid bacteria.
Probiotics market technical advances are a significant factor that is projected to fuel global demand growth over the forecast period. In addition, a growing global obesity population and prevalence of non-communicable diseases are expected to further fuel the target market growth during the projected period. Further, enhanced public health understanding and increased demand for bacillus coagulan products are projected to fuel target consumer growth over the forecast period in developing economies. Strict government regulations on probiotic approval are, however, an important factor to curb global market growth over the forecast period. More and more people's health concerns and increased demand for functional foods worldwide should generate profitability for the players on the global market during the forecast period. Increasing manufacturers' investments in research and development activities in new probiotics products and the launch of related new products are also expected to provide the target market opportunities. Manufacturers operating in the target market focus more closely on developing innovative goods and enhance their product portfolio through strategic business activities such as mergers, acquisitions and so on.
Due to rising health issues around the world and increased demand for functional foods, the global market for Bacillus Coagulans saw substantial growth opportunities. Furthermore, rising R&D spending is fueling business demand. However, customer perception of bacillus coagulans' efficacy hampers market development. Rising demand is projected to provide business growth opportunities for bacillus coagulan products in developing economies.
The global bacillus coagulans market holds significant revenue shares in Asia Pacific with ASEAN, India and China added to prominent markets for bacillus coagulans. The next in line after Asia-Pacific is North America. In view of the developing healthcare expenditure, Asia Pacific is also expected to be a fast-growing region. Due to widespread understanding of herbal medicine in the region, Japan is considered an important market for bacillus coagulans in the probiotic field. Southeast Asian countries such as India, with the growing acceptance of medical goods, are also expected to help the market growth of bacillus coagulans.
Increasing Burden of Chronic Digestive Diseases Worldwide
Lifestyle and diet modification leads to a spike in chronic digestive disorders worldwide. New clinical and laboratory trials have shown that bacillus coagulans help enhance digestive wellbeing and encourage a strong immune system. Close to 20% of the people who use antibiotics have antibiotic diarrhoea, with bacillus coagulans shown to be an effective remedy. In severe intestinal conditions, the beneficial effects of the bacillus cocagulans contribute to increased food and drink intake. Many food and drink firms add bacillus coagulants to their products, targeting a large number of people with digestive disorders. Chronic digestive disorders including gastrointestinal function, alcohol-related disorders, digestive cancers, and pediatric digestive diseases have grown, as stated by United European Gastroenterology (UEG). Around 28% of deaths linked to cancer in Europe are due to digestive cancers. Bacillus coagulans are a trendy probiotic that promotes gastrointestinal wellbeing. In weight control, bacillus coagulans use is growing increasingly as they have demonstrated to have an effective fat burner and promotes metabolism.
Some of the prominent players in the bacillus coagulans market include Microbax, Sabinsa, Ganeden, Mitsubishi, Nebraska Cultures, Syngen Biotech, Synbiotech, Sanzyme, and others.
The global bacillus coagulans market is segmented as below:
Bacillus Coagulans Market By Product
Bacillus Coagulans Market By Application
Bacillus Coagulans Market By Geography
Middle East & Africa
The market for bacillus coagulans is expected to reach a market value of around US$ 130 Mn by 2027
The bacillus coagulans market is expected to grow at a CAGR of around 8% from 2020 to 2027.
The pharmaceutical type is the leading segment by product in the bacillus coagulans market.
Probiotic activity of bacillus coagulans opens a lucrative avenue for functional food makers who have been increasing investment in expanding the portfolio of digestive products.
Microbax, Sabinsa, Ganeden, Mitsubishi, Nebraska Cultures, Syngen Biotech, Synbiotech, Sanzyme, and others are the prominent players in the market.
North America held the highest market share in the bacillus coagulans market.
Asia Pacific is expected to be the fastest growing market over the forecast period.